COMMUNIQUÉS West-GlobeNewswire

MyCardiologist Opens New Ambulatory Care Center in Miami Lakes, Expanding Access to Outpatient Cardiovascular Care
20/10/2026
MyCardiologist Ambulatory Care Center provides specialized cardiovascular procedures in an outpatient setting and strengthens MyCardiologist’s ability to care for patients throughout South Florida MIAMI LAKES, Fla., Oct [...]
ITM and Lumara Bio Announce Dose-Response Analysis for ¹⁷⁷Lu-edotreotide (ITM-11) and Data Supporting Early-Stage Pipeline at EANM 2026
20/10/2026
Dose-response analysis from Phase 3 COMPETE trial shows an association between higher absorbed doses of ¹⁷⁷Lu-edotreotide in tumors and improved clinical response in GEP-NETs Separate independent, investigator-led [...]
Maxion Therapeutics Appoints Biopharma Leader Mikael Dolsten to Board of Directors
20/10/2026
Former Pfizer Chief Scientific Officer and President of Worldwide Research, Development and Medical brings deep experience translating scientific innovation into life-changing medicines for patients CAMBRIDGE, United [...]
KFSH Brings Cardiac Catheterization Directly to Emergency Department to Accelerate Critical Care
20/10/2026
RIYADH, Saudi Arabia, Oct. 20, 2026 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSH) has established a dedicated Cardiac Catheterization Lab within the Emergency Department at its Riyadh [...]
Orikine Presents Preclinical Data Demonstrating Sustained Myeloid Reprogramming and Disease Control with ORK1 in Inflammatory Bowel Disease at UEG Week 2026
20/10/2026
A single dose of ORK1 generated durable disease control in two independent inflammatory bowel disease mouse models ORK1 induced sustained myeloid reprogramming, regulating chronic inflammation This data supports further [...]
Rapport Therapeutics Announces Positive Topline Results from its Phase 2 Trial of RAP-219 for the Treatment of Bipolar Mania
20/10/2026
The trial met the primary and secondary endpoints with statistically significant placebo-adjusted improvements at Week 3 in the YMRS total score (3.1 points; p=0.045) and CGI-BP Severity of Mania score (0.4 points; p=0. [...]
Leads Biolabs' Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Advances to Expansion Stage in Phase II First-Line Gastric Cancer Study
20/10/2026
Expansion Stage to Compare Opamtistomig Plus Chemotherapy Head-to-Head With Tislelizumab Plus Chemotherapy in Previously Untreated Disease NANJING, China, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Nanjing Leads Biolabs Co., Ltd [...]
Quoin Pharmaceuticals Announces Publication of Peer-Reviewed Paper on QRX003 for Netherton Syndrome in Dermatology and Therapy
20/10/2026
– Peer-Reviewed Paper Introducing QRX003 and Its Mechanism of Action in Netherton Syndrome Now Published – Case Report Details 21 Months of Compassionate Use Treatment in a Pediatric Patient – Patient’s Skin Improved [...]
BioNTech to Report Third Quarter 2026 Financial Results and Corporate Update on November 3, 2026
20/10/2026
MAINZ, Germany, October 20, 2026 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the third quarter 2026 on Tuesday, November 3, 2026. Additionally, the [...]
ABBYY Introduces PHOENIX Plus, Advanced AI Models Optimized for Intelligent Document Processing
20/10/2026
PHOENIX Plus expands automation to any document type while improving accuracy and straight-through processing rates AUSTIN, Texas, Oct. 20, 2026 (GLOBE NEWSWIRE) -- ABBYY introduces PHOENIX Plus , a native generative AI [...]
Abiologics Appoints Per Jr. Greisen as Chief Artificial Intelligence Officer
20/10/2026
AI protein design pioneer joins to advance first and only platform for de novo generation of synthetic D-protein therapeutics with supranatural properties WATERTOWN, Mass., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Abiologics, [...]
Visara Secures Exclusive Option for Potential Acquisition of YOL104-2 for Ocular Surface Squamous Neoplasia
20/10/2026
YOL104-2 is a bioengineered, trivalent, multifunctional peptibody incorporating a core interferon-mimetic with the potential to be a first-in-class therapy for Ocular Surface Squamous Neoplasia (OSSN) Visara is a [...]
Slate Medicines Strengthens Board of Directors with Appointment of Stephen K. Brannan, MD, and John D. Young
20/10/2026
RALEIGH, N.C., Oct. 20, 2026 (GLOBE NEWSWIRE) -- Slate Medicines, Inc. (“Slate”), a clinical-stage biotechnology company committed to advancing innovative new therapies that may broaden the treatment paradigm and [...]
Odyssey Therapeutics Presents Completed Phase 2a OD-001 Induction Results Strengthening Clinical Proof of Concept at UEG Week 2026
20/10/2026
Correlation between clinical efficacy and changes in inflammatory biomarkers, mucosal transcriptomic signatures, and histologic disease activity strengthens the previously shown clinical proof of concept for OD-001 [...]
Aclarion Publishes CEO Shareholder Letter Highlighting Continued Scan Volume Growth and Advancing Clinical Program in Third Quarter 2026
20/10/2026
85% year-over-year scan volume growth in Q3 2026, contributing to 117% growth for the nine months ended September 30, 2026 European Spine Journal publishes peer-reviewed data supporting MRS as a potential viable [...]
PolarityBio Highlights Highest Scoring Abstract Award and Presentation of Phase 3 COVER DFUS II Trial Results at SAWC Fall 2026
20/10/2026
“Autologous Cutaneous Multicellular Units in Non-Healing Wagner 1 Diabetic Foot Ulcers: Results of the Phase 3 COVER DFUS II Trial” honored with top award in Clinical Research category Pivotal Phase 3 trial met primary [...]
Mammogen Names National Cancer Screening Leader, Dr. Rebecca Kaltman, to Lead Pivotal genTRU-breast™ Study
20/10/2026
Executive Director of the Inova Saville Cancer Screening and Prevention Center will lead KATELYN-ERIN, Mammogen’s large prospective study evaluating its blood-based RNA assay to support breast cancer detection NEWPORT [...]
Kane Biotech Signs Distribution Agreement with The Stevens Company
20/10/2026
Expands Kane Biotech’s commercial footprint and access to the revyve ® product line across Canada WINNIPEG, Manitoba, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company”, “Kane” or “Kane [...]
Zevra Therapeutics Announces Details for Q3 2026 Financial Results Call
20/10/2026
BOSTON, Oct. 20, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on bringing life-changing therapeutics to people living with rare diseases [...]

Pages